SCHEMBL7032142

SCHEMBL7032142

COC(=O)C(CO)NC(=O)OCC[Si](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MME P08473 2/20 0.36
TGFBR1 P36897 1/20 0.35
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KYNU Q16719 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
ITGB3 P05106 3/20 0.31
ITGA2B P08514 3/20 0.31
ACHE P22303 1/20 0.31
ATM Q13315 1/20 0.31
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23781491 0.87 CHRNB2 (0.35) CYP2C9ACHECHRNB2CHRNB4CHRNA3
SCHEMBL16862539 0.87 CHRNB2 (0.35) CYP2C9ACHECHRNB2CHRNB4CHRNA3
SCHEMBL9162663 0.87 TGFBR1 (0.46) MMETGFBR1ALDH1A1
SCHEMBL16862569 0.85 KDM4E (0.33) THRBKYNUTAS1R3TAS1R1ITGB3
SCHEMBL28537199 0.85 KDM4E (0.33) THRBKYNUTAS1R3TAS1R1ITGB3
SCHEMBL7328622 0.85 TAS1R3 (0.46) TAS1R3TAS1R1
SCHEMBL20338029 0.84 CASP1 (0.36) KYNUITGB3ITGA2BACHEATM
SCHEMBL17841822 0.84 CASP1 (0.36) KYNUITGB3ITGA2BACHEATM
SCHEMBL21523341 0.83 ITGB3 (0.32) ITGB3ITGA2B
SCHEMBL16862526 0.83 ITGB3 (0.32) ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6569411-B2 Deodoring, microbiocides, marking odors THE GILLETTE COMPANY 2003-05-27 US disclosed
US-20030018055-A1 Serine carbonates FRATER GEORGE (CH) 2003-01-23 US disclosed
EP-1053223-A1 SERINE CARBONATES Givaudan SA (CH) 2000-11-22 EP disclosed
WO-2000034232-A1 SERINE CARBONATES GIVAUDAN SA (CH) 2000-06-15 WO disclosed
EP-1008587-A1 Serine carbonates Givaudan Roure (International) S.A. (CH) 2000-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018055-A1 Serine carbonates SRR, ME1, TASP1 MME 997/4885TGFBR1 2295/4885ALDH1A1 749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.